UncategorizedWhen zero doesn’t mean zero: the limits of coronary calcium in women Empower Meds / October 4, 2025
UncategorizedGene therapy startup targets ‘aging itself’ to combat blinding disease Empower Meds / October 3, 2025
UncategorizedLifeVantage completes acquisition of LoveBiome – Longevity.Technology Empower Meds / October 3, 2025
UncategorizedKlotho Neurosciences signs LOI to acquire Turn Biotechnologies assets – Longevity.Technology Empower Meds / October 3, 2025
UncategorizedMolecule shows skin longevity potential in sun aging study Empower Meds / October 2, 2025
UncategorizedAlnylam begins global Phase 3 trial dosing of zilebesiran – Longevity.Technology Empower Meds / October 2, 2025
UncategorizedBiomed reports positive Phase 2 results for new oral obesity drug NA-931 – Longevity.Technology Empower Meds / October 2, 2025
UncategorizedRokit America to scale operations in the Americas as regenerative hub – Longevity.Technology Empower Meds / October 2, 2025
